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Abstract
The midbrain periaqueductal grey (PAG) is a structure known for its roles in pain transmission and
modulation. Noxious stimuli potentiate the glutamate synaptic transmission and enhance glutamate
NMDA receptor expression in the PAG. However, little is known about roles of NMDA receptor
subunits in the PAG in processing the persistent inflammatory pain. The present study was
undertaken to investigate NR2A- and NR2B-containing NMDA receptors in the PAG and their
modulation to the peripheral painful inflammation. Noxious stimuli induced by hind-paw injection
of complete Freund's adjuvant (CFA) caused up-regulation of NR2B-containing NMDA receptors
in the PAG, while NR2A-containing NMDA receptors were not altered. Whole-cell patch-clamp
recordings revealed that NMDA receptor mediated mEPSCs were increased significantly in the
PAG synapse during the chronic phases of inflammatory pain in mice. PAG local infusion of Ro 25-
6981, an NR2B antagonist, notably prolonged the paw withdrawal latency to thermal radian heat
stimuli bilaterally in rats. Hyperoside (Hyp), one of the flavonoids compound isolated from
Rhododendron ponticum L., significantly reversed up-regulation of NR2B-containing NMDA
receptors in the PAG and exhibited analgesic activities against persistent inflammatory stimuli in
mice. Our findings provide strong evidence that up-regulation of NR2B-containing NMDA
receptors in the PAG involves in the modulation to the peripheral persistent inflammatory pain.
Background
Brainstem descending pathways linking the periaqueduc-
tal gray (PAG), the rostral ventromedial medulla (RVM),
and the spinal cord constitute a major mechanism in the
modulation of pain transmission [1,2]. Considerable evi-
dence has recently emerged regarding participation of this
system in persistent pain conditions such as inflamma-
tion and neuropathy. Recent studies indicate that persist-
ent pain after tissue or nerve injury is linked to an
enhanced activation of descending modulatory circuits
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after injury likely reflects long-lasting changes in synaptic
efficacy, similar to that seen in hippocampal synapses that
are involved in learning and memory[3,4]. The increased
net descending facilitatory drive leads to an amplification
of the pain [2,5-8]. However, the cellular mechanisms
underlying injury-induced synaptic plasticity in PAG cir-
cuitry are poorly understood.
Although PAG has limited direct projections to the spinal
cord, it has a key role in the descending modulation of
nociception and uses the RVM as an important intermedi-
ate in pain modulation, a site that projects directly to the
spinal cord dorsal horn [5,9-11]. Glutamate and GABA
play a critical role in processing pain at the PAG-RVM level
[12].
Studies have shown that N-methyl-D-aspartate receptor
(NMDAR) contribute to persistent pain following nerve
and tissue injury [1,13]. Native NMDARs are composed of
NR1, NR2 (A, B, C, and D), and NR3 (A and B) subunits.
The formation of functional NMDARs requires a combi-
nation of NR1, an essential channel-forming subunit, and
at least one NR2 subunit. NMDARs are highly expressed
in the brain and subunit compositions may occur during
early development and in different brain areas [14-16].
Previous studies show that peripheral inflammation
increases the expression of NR2B-containing NMDARs
and enhanced neurotransmitter release in the anterior cin-
gulate cortex [4,17-19]. Inhibition of NR2B receptors by
administering selective NR2B receptor antagonists locally
into the anterior cingulate cortex or systemically, inhibits
inflammation- related allodynia [17]. Subcutaneous for-
malin injection has been shown to produce an immediate
increase of glutamate and aspartate in the spinal cord, and
antagonists administered peripherally or spinally reduce
pain following formalin injection [1,20]. NMDARs in
PAG play a key role in the ascending transmission of pain
[1,2,13,20,21]. However, little is known the role of NR2B-
containing NMDARs in the PAG in processing prolonged
peripheral inflammatory injury.
Hyperoside (Hyp), a flavonoid compound isolated from
a folk remedy, Rhododendron ponticum L., which shows
anti-inflammatory and analgesic activities [22]. However,
little is known the mechanisms of Hyp underlying the per-
sistent inflammatory pain processing. It is hopeful this
study could shed light on the clinical treatment of chronic
pain with traditional herbs.
In present study, we assessed the role of PAG NR2B recep-
tor in processing of persistent inflammatory pain induced
by left hindpaw injection of complete Freund's adjuvant
(CFA). Our results demonstrate that NR2B receptor is up-
regulated in the PAG and involves in the modulation to
the prolonged peripheral injury.
Results
Up-regulation of NR2B receptors in the PAG after 
peripheral injury
Transgenic over-expression of NR2B-containing NMDARs
in forebrain areas enhances inflammatory pain in mice
[23]. Similarly, our previous results show that NR2B
expression is increased in the anterior cingulated cortex
after hindpaw CFA injection induced inflammatory pain
[17]. As PAG plays important roles in processing pain-
related information [1,6,20], it raises the possibility that
NR2B expression is changed in the PAG after injury. To
test this hypothesis, NR2B expression was examined by
Western blot analysis on total PAG homogenates from
mice. Western blot results showed that NR2B expression
in PAG was notably increased at 3d after CFA-injection
(234.4% ± 41.5% of saline, n = 6, p < 0.01; Fig. 1). Similar
to NR2B, AMPA receptor GluR1 subunit expression was
also increased after injury (189.4% ± 26.5% of saline, n =
6, p < 0.01; Fig. 1). However, no significant alteration was
detected in the NR2A expression in the PAG after injury
(Fig. 1). To further evaluate roles of NR2B receptor in
inflammatory pain modulation, we treated CFA-injected
mice with Hyp which shows anti-inflammatory and anal-
gesic activities [22]. NR2B expression was significantly
reduced in the PAG of CFA-injected mice administrated
with Hyp (100 mg/kg, i.g. twice daily for 3 days) (132.1%
± 26.8% saline, n = 6, p < 0.05 vs CFA-injected alone; Fig.
1B). These findings imply that changes in NMDARs are
selective for NR2B subunit in the PAG.
To further confirm the selective changes of NMDA recep-
tor subunits in PAG after CFA-injection, we performed
immunostaining in the midbrain sections containing the
PAG in mice. As shown in Fig. 2, expression of NR2B sub-
unit was significantly increased in the LPAG of CFA-
injected mice (n = 5) as compared with control mice (n =
6). Contrary to the NR2B, NR2A subunit was not signifi-
cantly changed (n = 5). Administration of Hyp (100 mg/
kg, i.g. twice daily for 3 days) reversed up-regulation of
NR2B subunit in the LPAG of CFA-injected mice.
Enhanced NMDAR-mediated synaptic transmission after 
injury
To test whether up-regulation of NR2B receptor leads to
changes in NMDAR-mediated synaptic transmission, we
measured NMDAR-mediated miniature excitatory postsy-
naptic currents (mEPSCs) in the presence of CNQX (an
AMPA receptor antagonist) in the lateral periaqueductal
gray (LPAG). The amplitude, not the frequency of
NMDAR-mediated mEPSCs was significantly increased at
LPAG synapses of CFA-injected mice compared with
saline controls (Frequency: saline, 0.38 ± 0.07 Hz, CFA,Page 2 of 10
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CFA, 13.8 ± 1.4 pA, n = 8, p < 0.05 vs saline; Fig. 3). As we
predicted, Hyp reversed the enhanced NMDAR-mediated
transmission in the PAG of CFA-injected mice (Frequency:
0.42 ± 0.05 Hz, n = 6; amplitude: 11.3 ± 1.1 pA, n = 8, p <
0.05 vs CFA-injected alone; Fig. 3). It suggests a possible
mechanism for an enhancement in NMDAR function is
an up-regulation of NR2B-containing NMDARs in the
PAG.
No changing of basal glutamatergic synaptic 
transmissionafter injury
Previous studies show that hindpaw injection of CFA
causes an enhancement in synaptic transmission in the
ACC [19,24]. To determine whether nocuous stimuli
affect basal glutamatergic synaptic transmission in the
PAG, we measured the AMPA receptor-mediated mEPSCs.
As shown in Figure 4, no significant alteration was
detected in the AMPA receptor-mediated mEPSCs fre-
quency and amplitude among the control, CFA-injected
and Hyp treated mice (n = 6, Fig. 4). Results indicate that
inflammatory painful stimuli have no effect on the basal
excitatory synaptic transmission in the PAG.
Behavioral responses to inhibition of NMDARs
Our results show that NR2B expression is increased in the
PAG after peripheral injury, suggesting that inhibition of
the NR2B subunit may alter inflammation -induced
behavioral responses. To test this hypothesis, we microin-
jected AP-5 (an NMDAR antagonist) and Ro 25-6981 (a
selective NR2B antagonist) into the PAG of rats and eval-
uated the effects on thermal hyperalgesia induced by CFA-
injection (Fig. 5A). The paw withdrawal latency (PWL) to
thermal radian heat stimuli is a widely used nociceptive
measure to study hyperalgesic behavior. As illustrated in
Fig. 5, CFA-treated ipsilateral paws (left) showed a signif-
icant decrease in PWL when compared to left paws of con-
trol rats (from 12.6 ± 1.2 s to 6.8 ± 0.7 s, n = 10, p < 0.01
vs CFA-injected alone; Fig. 5B). Interestingly, PWL in con-
tralateral paws (right) also showed a slight decrease when
compared to right paws of control rats (from 12.9 ± 1.4 s
to 9.8 ± 1.0 s; n = 11, p < 0.05 vs CFA-injected alone; Fig.
5C). Microinjection of Ap-5 (0.5 μg/0.5 μl) into the PAG
induced a significant increase in PWL in CFA injected rats
(ipsilateral: 11.8 ± 1.2 s, n = 5, p < 0.05 vs saline microin-
jection, Fig. 5B; contralateral: 12.1 ± 1.4 s, n = 5, p < 0.05
vs saline microinjection, Fig. 5C). Similar results were
observed for PWL with the microinjection of Ro 25-
6981(0.5 μg/0.5 μl) into the PAG (ipsilateral: 11.2 ± 1.1 s,
n = 5, p < 0.05 vs saline microinjection, Fig. 5B; contralat-
eral: 11.5 ± 1.6 s, n = 5, p < 0.05 vs saline microinjection,
Fig. 5C).
Inhibiting thermal hyperalgesia by Hyp
As illustrated in Fig. 1 and Fig. 2, administration of Hyp
reversed up-regulation of NR2B receptors in the PAG of
CFA-injected rats, it is reasonable to predict Hyp inhibit-
ing the thermal hyperalgesia induced by chronic inflam-
mation. As shown in Fig. 6, administration of Hyp (100
mg/kg, i.g. twice daily for 3 days) alone did not change
PWL in hindpaw saline-injected rats. However, Hyp could
significantly reverse ipsilateral PWL (from 7.2 ± 0.9 s to
11.8 ± 1.3 s; n = 8, p < 0.05 vs CFA-injected alone; Fig. 6B)
and contralateral PWL (from 10.2 ± 0.6 to 12.1 ± 0.7 s; n
= 8, p < 0.05 vs CFA-injected alone; Fig. 6B) in CFA-
injected rats.
To test whether analgesic effect of Hyp is associated to its
peripheral anti-inflammatory actions, we evaluate degree
Up-regulation of NR2B receptors in PAG after injuryFigure 1
Up-regulation of NR2B receptors in PAG after injury. 
(A) Western blot results showed that the expression level 
of GluR1 and NR2B receptors, but not NR2A receptor, was 
increased in the PAG after CFA injection. Hyp reversed 
expression level of GluR1 and NR2B receptors. (B) Sum-
mary of expression of NR2A, NR2B, GluR1 receptors in the 
PAG after CFA-injection. Values were significantly different 
from saline control ** p < 0.01; from CFA-injected alone # p 
< 0.05.Page 3 of 10
(page number not for citation purposes)
Molecular Pain 2009, 5:71 http://www.molecularpain.com/content/5/1/71of edema by measuring the volume of hindpaw. Paired t-
test showed a significant increase in the volume of the
CFA-injected paws when compared to contralateral paws
(inflamed paws: 1.6 ± 0.2 ml, contralateral paws: 0.7 ± 0.1
ml, n = 8, p < 0.01; Fig. 6C). However, administration of
Hyp (100 mg/kg, i.g. twice daily for 3 days) had no effects
on the volume of the CFA-injected paws (CFA: 1.6 ± 0.2
ml, CFA + Hyp:1.5 ± 0.3 ml, n = 8; Fig. 6C).
Discussion
PAG and adjacent structures constitute a pain-control sys-
tem that descends from the brain onto the spinal cord.
Considerable evidence has recently emerged regarding
participation of this system in persistent pain conditions
such as inflammation and neuropathy [2,5-8,25-27]. An
increasing number of studies have shown that the
descending system can facilitate spinal transmission of
pain signals during persistent nociception. Anatomical,
electrophysiological and pharmacological evidence has
established the RVM as an integral relay in descending
modulation of nociception, including that elicited by
PAG stimulation [5,10,28]. Fields et al. [29] have charac-
terized ON and OFF cells in the RVM that may constitute
the physiological basis for generation of bidirectional
modulation of spinal nociceptive transmission. Off-cells
are proposed to contribute to inhibitory influences, while
ON-cells are proposed to contribute to facilitatory influ-
ences that descend from the RVM. Projections from PAG
modulate the state of ON or OFF cells in RVM and trigger
descending facilitation or inhibition [6].
NMDARs in the cortex, PAG, and RVM play a key role in
the ascending transmission of pain [1,2,12,13,20,21].
Recently, chemical or electrical stimulation in the rat ante-
rior cingulate cortex (ACC), which sends projections to
the PAG and thus communicates indirectly with the RVM,
enhanced the tail-flick reflex [18,30-32]. Persistent
peripheral inflammation leads to enhanced presynaptic
glutamate release in the ACC [19,33,34]. Microinjection
of NR2B antagonist into the ACC significantly reduces
mechanical allodynia induced by hindpaw CFA-injection
[17]. Microinjection of NMDA into the RVM facilitate the
tail-flick reflex in a dose-dependent manner, an effect
blocked by the NMDAR antagonist AP-5 [35,36]. How-
ever, little is known the roles of NR2B-containing
NMDARs in the PAG in processing the peripheral persist-
ent inflammatory pain.
In present investigation, we demonstrate for the first time
that changes in NMDARs expression in the PAG is selec-
Immunostaining of NMDA receptors in PAGFigure 2
Immunostaining of NMDA receptors in PAG. Immunostaining was performed in the coronal midbrain slices containing 
the PAG. (A) Expression of NR2A in saline control, CFA, and CFA + Hyp treated mice. (B) Expression of NR2B in saline con-
trol, CFA, and CFA + Hyp treated mice. Scalebar (in B): A, B, 500 μM. DMPAG: Dorsomed periaqueductal gray; LPAG: Lateral 
periaqueductal gray.Page 4 of 10
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onstrate a significant increase in NR2B expression in the
lateral areas of the PAG (LPAG). Up-regulation of NR2B is
verified by the recordings of NMDAR-mediated mEPSCs.
It is reasonable to conclude that the enhancement in
NMDARs is due to the up-regulation of NR2B-containing
NMDARs in the PAG. Different reports have shown that
phosphorylation of the NMDAR NR1 subunit is associ-
ated with noxious stimulation demonstrated by capsaicin,
carrageenan and formalin injection to rodents [37-39].
We do not exclude the possibility that NMDAR NR1 sub-
unit is altered in our experiment condition.
The increased descending facilitatory drive from the PAG
and RVM leads to an amplification of the pain. Hindpaw
CFA-injection induced inflammation is an animal model
for persistent inflammatory pain which nociceptive path-
way involves anatomical sites at the level of the brain, spi-
nal cord, and periphery. As shown in many other studies
the inflamed ipsilateral paws show a significant decrease
in PWL than control paws [40,41]. Also, the contralateral
paws of CFA-injected group show a slight decrease in PWL
than control paws, even though the decrease in PWL of
contralateral paws is much smaller than that on the ipsi-
lateral side [42]. This indicates that in chronic inflamma-
tory pain condition the decrease in PWL to thermal
stimuli is not confined only to the CFA-inoculated paws
but also affects the non-inoculated contralateral paws.
Consistent with this report, we find that unilaterial CFA
injection causes a bilateral decrease in PWL in present
study. PAG infusion of NR2B antagonist, Ro 25-6981,
leads to prolong PWL bilaterially, suggesting the NR2B-
containg NMDARs in the PAG modulate the thermal
hyperalgesia to peripheral inflammatory injury.
However, it is important to define in which circumstances
the descending system is inhibitory and in which it is
facilitatory. The problem is that, even for similar types of
experiment, some laboratories conclude that the descend-
ing system has an inhibitory role in nociception while
other laboratories conclude that it has a facilitatory role
[5,6,10,28]. The similar contradiction is observed in the
experiments to define the role of NMDARs in the PAG in
descending system. In some experiments show that activa-
Enhanced NMDA receptor-mediated transmission after injuryFigure 3
Enhanced NMDA receptor-mediated transmission after injury. (A) NMDA receptor-mediated mEPSCs recorded in 
PAG neurons at a holding potential of -30 mV. Representative traces show NMDA receptor-mediated mEPSCs in the saline, 
Hyp, CFA, and CFA + Hyp treated mouse. (B) Cumulative frequency (left) and amplitude (right) histogram of the mEPSCs 
from the cells in (A). Filled circles, from a saline control mouse; open circles, Hyp treated mouse; filled trangles, from a CFA-
injected mouse; open trangles, from a CFA + Hyp treated mouse. (C) Summary of mEPSCs frequency (left) and amplitude 
(right) in neurons from the saline, Hyp, CFA, and CFA + Hyp treated mice. Values were significantly different from saline con-
trol * p < 0.05; from CFA-injected alone # p < 0.05.Page 5 of 10
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response [21,43,44], while others show that NMDARs
may play a critical role in induction of spinal hyperalgesia
after prolonged noxious stimulation [1,2,20]. One way to
solve this apparent contradiction is to hypothesize that
experiments are performed in different conditions, such
as intense of noxious stimuli (acute or chronic), types of
injury (inflammatory or neurophathic), time points after
induction of injury.
Interestingly, present results indicate that basal excitatory
synaptic transmission is not altered in the LPAG synapse
following exposure to peripheral inflammation. This is
demonstrated by unchanged AMPA receptor-mediated
mEPSCs frequency and amplitude in PAG slice record-
ings. However, GluR1 subunits were found over-
expressed in the PAG by Western-Blot detection. At least
two possible mechanisms may explain this difference.
First, mEPSC recordings could only detect the surface
expression of AMPA receptors while Western-blot analysis
indicates the total APMA receptors including the cytoplas-
tic distribution. Previous reports suggest that synaptic
delivery of the GluR1 subunit from extrasynaptic sites and
cytoplasm is the key mechanism underlying synaptic plas-
ticity and pain recessing [33,45-47]. Second, mEPSC
recordings were performed in the LPAG while the tissues
for Western-blot analysis were from the whole PAG in
present study.
To further confirm the selective changes of NMDARs sub-
units in PAG after CFA-injection, we treated the CFA-
injected mice with Hyperoside (Hyp), a flavonoid com-
pound isolated from a folk remedy, which shows anti-
inflammatory and analgesic activities [22]. In the present
study, we found Hyp significantly reversed the up-regu-
lated NR2B receptors in the PAG from mice with periph-
eral injury, whereas it did not affect the NR2B receptor
expression in the normal physiological conditions. The
down-regulated NR2B receptor is quite correlated with its
analgesic effects on the thermal hyperalgesia induced by
chronic inflammation. When evaluated its peripheral
anti-inflammatory activities, we found that Hyp had mar-
ginal effect on the paw edema by CFA-injection. The data
suggest analgesic effects of Hyp involving the modulation
of synaptic transmission at the level of PAG. However, we
could not exclude the possible effects of Hyp on the pain
transmission through modulation of algesic mediators,
e.g. TNF, substance P, bradykinin, or serotonin.
Basal glutamatergic synaptic transmission in the PAGFigure 4
Basal glutamatergic synaptic transmission in the PAG. (A) AMPA receptor-mediated mEPSCs recorded in PAG neu-
rons at a holding potential of -70 mV.Representative traces show AMPA receptor-mediated mEPSCs in the saline, Hyp, CFA, 
and CFA + Hyp treated mouse. (B) Cumulative frequency (left) and amplitude (right) histogram of the mEPSCs from the cells 
in (A). Filled circles, from a saline control mouse; open circles, Hyp treated mouse; filled trangles, from a CFA-injected mouse; 
open trangles, from a CFA + Hyp treated mouse. (C) Summary of mEPSCs frequency (left) and amplitude (right) in neurons 
from the saline, Hyp, CFA, and CFA + Hyp treated mice.Page 6 of 10
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up-regulation of NR2B-containing NMDARs in the PAG
involves in the modulation to the peripheral injury. It is
hopeful this study could help further understand NR2B-
containing NMDARs function during chronic pain
processing and descending facilitation.
Methods
Animals
Six- to eight-week-old male C57BL/6 mice and Sprague
Dawley rats were used in the experiments. All animal pro-
tocols used were approved by the Animal Care and Use
Committee of the Fourth Military Medical University.
Animals were housed under a 12 h light/dark cycle with
food and water provided ad libitum. To induce inflamma-
tory pain, 10 μl (for mouse) or 50 μl (for rat) of 50% CFA
(Sigma, St. Louis, MO) was injected subcutaneously into
the dorsal surface of left hindpaw. The degree of edema
was evaluated by measuring hindpaw volume using a
plethysmometer (UgoBasile, Varese, Italy). All experi-
ments were performed 3-5 days after hindpaw CFA-injec-
tion.
Western blot
Equal amounts of protein (50 μg) from the PAG of mice
were separated and electrotransferred onto PDVF mem-
branes (Invitrogen), which were probed with anti-NR2A,
anti-NR2B, anti-GluR1 (Chemicon), and with β-actin
(Sigma) as a loading control. The membranes were incu-
bated with horseradish peroxidase conjugated secondary
antibodies (anti-rabbit IgG for the primary antibodies),
and bands were visualized using an ECL system (Perkin
Elmer).
Immunohistochemistry
Immunostaining was performed as described previously
[48]. Briefly, the PAG sections from mice were first treated
with 0.75% Triton X-100 and 1% H2O2 in PBS for 1 h, and
then processed for 30 min in 3% normal goat serum, fol-
lowed by incubation with anti-NR2A and anti-NR2B, anti-
GluR1 (Chemicon) monoclonal antibody overnight at
room temperature. Secondary reactions with biotinylated
goat anti-mouse immunoglobulin (Vector Laboratories)
for 1 h were followed by avidin- biotin-peroxidase com-
plexes (Vector Laboratories) for 1 h. A nickel-intensified
diaminobenzidine with glucose oxidase was used as the
final chromogen. Sections were washed several times,
mounted on gelatinized slides, dehydrated through a
series of ethanol solutions, cleared in xylene, and covered
with glass coverslips. Controls, performed by replacing
primary antibody with 1% NGS in the protocol.
Slice preparation and Whole-cell patch-clamp recordings
Coronal brain slices (300 μm), containing the PAG, were
prepared as described [49,50]. Slices were transferred to
submerged recovery chamber with oxygenated (95% O2
and 5% CO2) artificial cerebrospinal fluid (ACSF) con-
taining (in mM): 124 NaCl, 2.5 KCl, 2 CaCl2, 2 MgSO4, 25
NaHCO3, 1 NaH2PO4, 10 glucose at room temperature
for at least 1 h. Experiments were performed in a recording
chamber on the stage of an Axioskop 2FS microscope with
infrared DIC optics for visualization of whole-cell patch-
Changes in the PWL by AP-5 and Ro 25-6981Figur  5
Changes in the PWL by AP-5 and Ro 25-6981. (A) Representative coronal section of rat midbrain showing PAG injec-
tion sites. Scale bar, 500 μm. Aq: aqueduct; DMPAG: Dorsomed periaqueductal gray; LPAG: Lateral periaqueductal gray. (B) 
PWL in the CFA-treated paws (ipsilateral) by AP-5 and Ro25-6981 infusion. (C) PWL in the right hind paws (contralateral) by 
AP-5 and Ro25-6981 infusion. Values were significantly different from saline control * p < 0.05, ** p < 0.01; from CFA-injected 
alone # p < 0.05.Page 7 of 10
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rents (mEPSCs) were recorded from LPAG neurons with
an Axon 200B amplifier (MDS, Inc., CA). AMPA receptor-
mediated mEPSCs were recorded from the neurons
clamped at -70 mV. The recording pipettes (3-5 MΩ) were
filled with solution containing (mM) 145 K-gluconate, 5
NaCl, 1 MgCl2, 0.2 EGTA, 10 HEPES, 2 Mg-ATP, and 0.1
Na3-GTP (adjusted to pH 7.2 with KOH). The NMDAR-
mediated component of mEPSCs was pharmacologically
isolated in ACSF containing CNQX (20 μM), glycine (1
μM), TTX (0.5 μM). The patch electrodes contained 102
mM cesium gluconate, 5 mM TEAchloride, 3.7 mM NaCl,
11 mM BAPTA, 0.2 mM EGTA, 20 mM HEPES, 2 mM
MgATP, 0.3 mM NaGTP, and 5 mM QX-314 chloride
(adjusted to pH 7.2 with CsOH). Neurons were voltage
clamped at -30 mV. Picrotoxin (100 μM) was added in the
ACSF for the all recordings. Access resistance was 15-30
MΩ and monitored throughout the experiment. Data
were discarded if access resistance changed more than
15% during an experiment.
Surgery and microinjection
Cannula implantation was performed according to the
procedure by Ghelardini [20]. Rats were implanted with
7-mm stainless steel guide cannula (23-gauge) into the
right sige of PAG (6.8 mm posterior to Bregma, 0.5 mm
lateral from the midline, 4.5 mm beneath the surface of
the skull) with the guide cannula angled 26° to the verti-
cal. The dummy cannulas, cut 0.5 mm longer than guide
cannulas, were inserted into the guide cannulas to prevent
clogging and reduce the risk of infection. Rats were given
at least 5 days to recover before experimentation. A 30-
gauge injection cannula that was 1.5 mm lower than the
guide was used for drug infusion. AP-5 (0.5 μg/0.5 μl),
Ro25-6981 (0.5 μg/0.5 μl) or saline was delivered at the
rate of 0.5 μl/min using a pump. After infusion, the can-
nulas were left in place for an additional 2 min to allow
the solution to diffuse away from the cannula tip.
Measurement of thermal hyperalgesia
The method of Hargreaves et al. (1988) was used to assess
paw withdrawal latency (PWL) to a thermal nociceptive
stimulus [41]. To assess thermal nociceptive responses, a
commercially available plantar analgesia instrument
(BME410A, Institute of Biological Medicine, Academy of
Medical Science, China) was used. Animals were placed in
individual plastic boxes and allowed to adjust to the envi-
ronment for 1 h. Thermal hyperalgesia was assessed by
Changes in the PWL by HyperosideFigur  6
Changes in the PWL by Hyperoside. (A) PWL in the CFA-treated paws (ipsilateral) from the control, Hyp, CFA + saline, 
and CFA + Hyp treated mice. (B) PWL in the right hind paws (contralateral) from the control, Hyp, CFA + saline, and CFA + 
Hyp treated mice. Values (in A and B) were significantly different from saline control * p < 0.05, ** p < 0.01; from CFA-injected 
alone, # p < 0.05. (C) Paw volume in the CFA-treated and contralateral paws from control and Hyp treated mice. Values (in 
C) were significantly different from contralateral paws ** p < 0.01.Page 8 of 10
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radiant heat source. Rats were housed individually into
Plexiglas chambers on an elevated glass platform, under
which a radiant heat source was applied to the plantar sur-
face of the hind paw through the glass plate. The heat
source was turned off when the rat lifted the foot, allowing
the measurement of time from onset of radiant heat appli-
cation to withdrawal of the rat's hindpaw. This time was
defined as the PWL. Both paws were tested alternately at
5-min intervals for a total of five trials. A 20 s cutoff was
used to prevent tissue damage. Both hindpaw was tested
independently with 10 min interval between trials.
Histological identification
To confirm the locations of the intra-PAG injection sites,
brains were fixed with 4% paraformaldehyde and dehy-
drated through an ascending alcohol series. The rat brains
coronal sections (30 μm) were mounted on glass slides
and stained with hematoxylin and eosin. Images were
taken using an Olympus light microscope equipped with
a CCD camera.
Data analysis
Results were expressed as mean ± SEM. Statistical compar-
isons were performed using a t-test, One-way ANOVA, or
Two-way Repeated Measures ANOVA with student's t-test
for post-hoc. In all cases, p < 0.05 was considered statisti-
cally significant.
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